Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2010-05-28 Major Shareholding Noti…
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D
Major Shareholding Notification
2010-05-28 English
Proxy Solicitation & Information Statement 2010
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is a solicitation of written consents from stockholders to approve proposals related to changes in the company's bylaws and board of directors. The document includes detailed information about the proposals, the background of the solicitation, and instructions for stockholders to submit their consents. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or consent solicitations. The document is not an announcement of a report, nor is it a full annual or interim report, earnings release, or other financial filing. Therefore, the correct classification is PSI with high confidence.
2010-05-28 English
Major Shareholding Notification 2010
Major Shareholding Notification
2010-05-17 English
Annual Report 2010
Annual Report Classification · 95% confidence The document is a detailed letter from CopyTele, Inc. to the SEC responding to comments on their previously filed Annual Report on Form 10-K/A for the fiscal year ended October 31, 2009. It discusses specific disclosures, modifications, and clarifications related to the 10-K/A filing, including business operations, license agreements, and financial terms. The presence of detailed financial and operational information related to the annual report, the reference to the Form 10-K/A, and the nature of the content as a response to SEC comments on the annual report indicate that this document is related to the Annual Report filing. The document length (15,000 characters) and substantive content confirm it is not a brief announcement or certification but a detailed report or amendment related to the annual report. Therefore, the appropriate classification is Annual Report (10-K).
2010-05-13 English
Regulatory Filings 2010
Regulatory Filings Classification · 90% confidence The document text is heavily encoded or encrypted and does not contain clear, readable content or identifiable keywords related to any specific financial filing type. There are no explicit references to report titles, fiscal periods, regulatory bodies, or typical filing indicators. The length of the document is 10,933 characters, which is substantial, but the content is not interpretable as a financial report or announcement. Given the lack of discernible information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific types.
2010-04-27 English
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a detailed letter from CopyTele, Inc. responding to comments from the SEC staff regarding their previously filed Form 10-K/A for the fiscal year ended October 31, 2009, and Form 10-Q for the quarter ended January 31, 2010. The letter addresses specific regulatory comments, clarifies disclosures, and proposes changes to the 10-K/A. It references the 10-K/A and 10-Q filings explicitly and discusses detailed business and financial disclosures. The document is lengthy (15,000 characters) and contains substantive content related to the annual report and quarterly report filings, not merely an announcement or certification. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a response letter to SEC comments rather than the actual 10-K or 10-Q report itself. It does not contain the full annual or quarterly report but is a regulatory correspondence related to those filings.
2010-04-12 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.